PEspeaks

Jan 25, 2018
Pharmaceutical Executive
Marc O'Connor discusses healthcare services, provider integration, and more insights from the 2018 JP Morgan healthcare conference.
Jan 24, 2018
Reflector reports on the EU's legislative move to push the fifty or so national and regional HTA organizations in Europe towards greater cooperation.
Jan 18, 2018
Manish Gupta discuss the current strengths and weaknesses of artificial intelligence applications in life sciences.
Jan 12, 2018
Pharmaceutical Executive
This post highlights the benefits of a new IT favorite for healthcare marketing, trigger emails.
Jan 12, 2018
Shared understanding of both risks and benefits to all parties in the healthcare continuum is essential in order to deliver more value, write Vickie Andros and Jake Caines.
Jan 10, 2018
If confirmed as the next secretary of the Department of Health and Human Services (HHS), Alex Azar says that a top priority is to make drugs more affordable.
Jan 09, 2018
Pharmaceutical Executive
The advent of immunocellular therapies marks a major milestone in medical innovation, but the path for these treatments in transforming patient care is still forming as they face challenges in clinical trials, pricing, and market acceptance.
Jan 08, 2018
Pharmaceutical Executive
Program puts a new—and very real—spin on patient nutrition.
Jan 07, 2018
Sponsored Content
This Q&A with Lumicell CEO Kelly Londy discusses new drug-device technologies in development for a range of cancers, beginning with breast cancer in the most advanced clinical studies.
Jan 03, 2018
William King offers five predictions on evolution of data and predictive insights that could be critical for pharma go-to-market strategies.
native1_300x100
lorem ipsum